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Introduction
Across the world, the recent situation of diabetes mellitus shows 
the gradual increasing prevalence in developed countries and 
developing countries.1 Consequently, the important problem would be 
the adequate management and treatment for diabetes mellitus.2 
For the therapeutic concept for diabetes, nutritional treatment has 
been the basal way of the therapy. There were a variety of dietary 
therapies until now, such as calorie restriction (CR), low carbohydrate 
diet (LCD), Mediterranean diet, high protein diet, vegetarian diet, 
Paleolithic diet and so on.3 Among them, CR had been formerly usual 
nutritional treatment method for diabetes.
After that, LCD has been introduced into the health field and 
medical practice.4 Consequently, Dietary Intervention Randomized 
Controlled Trial (DIRECT) Group reported the better efficacy of 
LCD5 and similar results with longer years.6 With various reports, 
the comparison studies between CR and LCD have been continued.7 
There are predominant clinical effects in LCD rather than CR. 
Recently, LCD has been known and spread in North American and 
European countries.8
On the other hand, LCD was launched in Japan by Dr. Ebe who is 
main researcher in our group.9 Successively, authors and colleagues 
have continued clinical research concerning LCD, related themes and 
ketones bodies.10 Among them, the author reported that the values of 
ketone bodies are extremely elevated in the axes of fetuses, placenta, 
newborn and pregnant women, indicating the significant physiological 
role of ketone bodies.11 
There are recently several reports concerning clinical efficacy of 
LCD.12,13 Through our clinical investigation, authors have combined 
research on CR/LCD meals and continuous glucose monitoring 
(CGM).14,15 Authors have continued the medical practice for female 
diabetic patients in women’s clinic. One of the cases with pregnant 
diabetic patient will be described in this article, associated with the 
detail investigation of LCD and CGM.
Case presentation
History of present illness: The enrolled patient was 27 year-old 
female for type 2 diabetes mellitus (T2DM). She has been treated 
using insulin for 5 years, and delivered the first child by Caesarean 
section 3 years ago. Her weight had been approximately 98 kg before 
the pregnancy. Her usual physique has been 165cm in height and 98 
kg in weight with Body Mass Index (BMI) 36.0. 
During current pregnancy, she had been treated in University 
Hospital. She was given the meal of 1600 kcal a day and insulin 
therapy. The insulin administration method has been multiple daily 
insulin injection (MDI). It includes Novo rapid (Novo Nordisk) 
three times a day and Insulin Glargine (Eli Lilly and Company) at 
night once a day. The former is Insulin Aspart provided by pre–
filled pen including 100units/mL, and the latter is Insulin Glargine 
by BS injection kit FFP including 300units/mL. The administration 
schedule of the insulin therapy was that Aspart is given 6, 6, 6 units 
on 0700h, 1200h, 1800h and Glargine is given 30 units on 2200h. 
For MDI therapy by University hospital, her HbA1c value was 
9.7% in 12 weeks, and 7.0% in 28 weeks of pregnancy. She showed 
a little hypertensive with stable condition until 28 weeks without 
preeclampsia symptom or other clinical problems during this period. 
Authors and colleagues have continued LCD treatment for various 
patients with T2DM and pregnancy cases, and LCD educational 
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Abstract
In the diabetic medical practice, continuous glucose monitoring (CGM) has been recently 
used with beneficial efficacy. Authors have continued women’s medical care and research 
on Calorie Restriction (CR) and Low Carbohydrate Diet (LCD), and developed medical 
and social LCD movement by Japan LCD Promotion Association (JLCDPA). In this 
study, a diabetic female case with remarkable improving effect is shown using CGM and 
LCD. The case is 27 years-old female with type 2 diabetes mellitus (T2DM). She has 
been pregnant and on multiple daily insulin injection (MDI) with insulin 48 units/day in 
the university hospital. She was on this treatment until 28th weeks with no preeclampsia 
symptoms, and hoped to change the treatment of LCD. She came to our women’s clinic 
with the current data of weight 101kg, BMI 37.1 and HbA1c 7.0%. By application of 
FreeStyle Libre (Abbott, USA), her glucose variability showed around 160mg/dL with some 
episodes of hyperglycemia. The meal was changed from CR to LCD after 29th week, then 
insulin administration could be discontinued in 10 days. This glucose variability showed 
remarkable efficacy for combination of LCD and CGM. These results would become basal 
and reference data and contribute to the development of future research.
Keywords: continuous glucose monitoring, low carbohydrate diet, glucose variability, 
Japan LCD promotion association, freestyle libre, registered dietitian nutritionist
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movement through the activity of Japan LCD Promotion Association 
(JLCDPA). This patient came to know the beneficial effect of LCD 
and hoped to be treated in our women’s clinic. Then, she visited our 
clinic for further evaluation and treatment for LCD at 28 weeks of 
pregnancy.
Physical examination: On the first contact in our women’s health 
and medical clinic, she showed 165 cm in stature and 101kg in body 
weight. Her Body Mass Index (BMI) was 37.1. Her consciousness 
was alert, and physicals were hypertensive and otherwise normal. 
There were no remarkable findings in her lung, heart, abdomen and 
neurological axis. Chest X-ray and Electrocardiogram (ECG) were 
unremarkable. 
Laboratory tests: The data of the basal blood chemistry were as 
follows: AST 40U/L, ALT 31U/L, Total Protein 6.2g/dL, BUN 11mg/
dL, Cre 0.3mg/dL, T-Cho 225mg/dL, TG 209mg/dL, HDL-C 67mg/
dL, complete blood count; RBC 458x104/μl, Hb 13.2g/dL, MCV 
89fL, WBC 7,910/μl, Platelet 20.1x104/μl, Fe 74μg/dL, UIBC 460μg/
dL, TIBC 534μg/dL, Ferritin 62.3ng/mL. Biomarkers concerning 
diabetes and ketone bodies were as follows: HbA1c 7.0%, blood 
glucose 145mg/dL, total ketone body 259μmol/L (-131), acetoacetic 
acid (AcAc) 56μmol/L (-55), 3-hydroxybutylic acid (3-OHBA) 
203μmol/L (-85). 
CR and LCD: Concerning the nutritional therapy, there have been 
two main diet therapies. One is CR and another is LCD. Formerly, CR 
was the basic meal for nutritional therapy in Japan. The PFC ratio of 
CR has been as 15: 25: 60. This has been the standard diabetic meal 
recommended by the Japan Diabetes Association (JDA).16 
In contrast, authors and colleagues have proposed three kinds of 
LCD, which are super LCD with 12%, standard LCD with 26% and 
petite LCD with 40% of carbohydrate.17 These protocol have been in 
applied in our studies, which are standard method of JLCDPA. In this 
case, super LCD meal with 12% of carbohydrate and 1600kcal per 
day was adopted. 
CGM: Daily profile of blood glucose was investigated by CGM. For 
detail study of CGM, we applied FreeStyle Libre which has been rather 
prevalent for practical study. It was produced by Abbott Diabetes Care 
Inc., Alameda, CA, USA.18 FreeStyle Libre has been evaluated to be 
simple and beneficial for detecting blood glucose variability. It is 
also so small size that each patient can manage it easily with precise 
continuous data of changing blood glucose.19 
Progress course: After the detail explanation and lecture of CR and 
LCD, she has understood the difference between the both well. She 
has recognized the significance of LCD and the consent for changing 
from CR to LCD. Furthermore, she started to measure the daily profile 
of blood glucose by CGM using FreeStyle Libre. 
Formerly, she was given CR meal for 1600kcal and insulin therapy 
in the university hospital. The CR meal and insulin was given until 
28th weeks of pregnancy, which was the same treatment as before. The 
glucose variability in 28th week is shown in Figure 1. Average glucose 
is around 160mg/dL, but hyperglycemia is observed after meals. The 
glucose variability showed variation with different time of blood 
glucose peak during 28th week.
After 29th week, she changed the meal from CR to LCD. Due to the 
decreasing blood glucose, insulin doses were reduced gradually day 
by day. The administration of insulin became unnecessary and was 
discontinued in 10 days. The glucose variability in 34th week is shown 
in Figure 2. The blood glucose variability was stable within normal 
range in preprandial and also postprandial period. She has continued 
to have various kinds of meal, such as egg, salmon, vegetables, meat 
winner, low carbo bread, and so on. Combined with the continuous 
advice of dietician nutritionists, she showed satisfactory clinical 
course after that with stable glucose variability and HbA1c level.
Figure 1 Glucose variability on 28th week by FreeStyle Libre. There are some 
episodes of hyperglycemia with HbA1c 7.0%.
Figure 2 Glucose variability on 34th week by FreeStyle Libre. There are almost 
no episodes of hyperglycemia with HbA1c 6.1%.
Discussion
In this article, we presented a case of a pregnant woman with 
obesity and T2DM. She was given 48 units / day of insulin until 
28 weeks. After that, she had further evaluation and treatment with 
CGM using FreeStyle Libre and LCD in our women’s clinic. Blood 
variability was remarkably improved in several days, and insulin 
administration was discontinued in 10 days. From these results, 
several medical aspects would be discussed.
The first is the clinical effect of LCD on diabetes. Dietary therapy 
for diabetes has been formerly CR. Later, the author and colleagues 
have introduced and spread the LCD for the first time in Japan.9 We 
have also reported clinical studies of research for LCD in thousands 
of people.20 
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Furthermore, the author showed a diabetic woman who 
dramatically improved the glucose variability when changing from 
CR to LCD.21 In addition, we have introduced three types of LCDs, 
which are super, standard, and petite LCDs.22 Thus, the movement 
of LCD has been spreading by books, lectures and clinical studies 
through the activities of the JLCDPA.23
The second is new knowledge in the field of female medicine. 
In other words, it relates to pre- and postpartum studies of pregnant 
women, as well as treatments for diabetes and pregnant women. There 
is the main theme of our research. In the clinical practice of LCD, 
elevation of blood ketone bodies has been an important finding and a 
crucial subject of research. 
The author reported the impressive data that high concentrations 
of ketone bodies continue in the blood at the pregnant woman-
placenta-fetus-newborn axis. In this system, the significance role of 
physiological ketone bodies would be recognized.11 In addition, we 
have experienced diabetic pregnant female cases in which the diabetic 
state dramatically improved with LCD rather than conventional CR 
and insulin treatment.
Thirdly, among such patients, one of the cases is described in this 
report. She was previously administered insulin totally 48 units per 
day. Until 28th week, she had showed a little hypertensive states, but 
did not eclampsia or other problems clinically. The content of the meal 
was changed from CR to LCD, in which the daily calorie intake is 
the same as 1600kcal. For comparison of CR vs LCD, the percentage 
of carbohydrates is 60% vs 12%, respectively, then the calories from 
carbohydrates are 960kcal vs 192kcal.22,23 Since 1g of carbohydrate 
has 4kcal in calorie, the amount of carbohydrate per day would be 
calculated as 240g vs 48g.
Thus, the carbohydrate intake was drastically reduced, so that the 
increase in blood sugar was suppressed. Consequently, diabetic state 
could be eventually improved in a short time to rather normal level 
where insulin administration became unnecessary in only 10 days. 
This would be clinically a prominent effect. 
Furthermore, when carbohydrate intake is reduced, fat can be 
burned and ketone bodies are produced. Ketone bodies play very 
important roles as energy sources.11 In recent years, clinical usefulness 
of ketone bodies has been reported, and it is possible to spend 
pregnancy period safely without an increase in blood glucose.24,25
From mentioned above, clinical usefulness of LCD was observed. 
In the cases of diabetes with pregnancy and gestational diabetes, 
further evaluation and research for LCD in practical use would be 
expected to be more important than conventional CR diet plus insulin 
therapy.
Fourthly, CGM has various research aspects for years. From the 
fundamental point of FreeStyle Libre, the enzyme electrode method 
was introduced long ago.26 After that, the method of electrode were 
developed and lots of experiments were continued for CGM.27 There 
was the guideline of CGM and the international standardization 
including precision absolute relative difference (PARD) and mean 
absolute relative deviation (MARD).28,29 
It is indeed that FreeStyle Libre shows the benefit for easy and 
accurate measurement of blood glucose variability. However, there is 
some discrepancy of HbA1c value between laboratory measurement 
and the estimated HbA1c level calculated by FreeStyle Libre. This 
is probably from the characteristics of measurement in every 15 
minutes.30 Furthermore, It cannot detect occasional glucose acute 
spike-like increase of glucose.31 Consequently, further evaluation with 
various data accumulation would be necessary in the future.
There is the description of recommendations for CGM in the 
guideline 2019.32 The beneficial points are found in the correlation 
with the adherence to continuous usage of this device FreeStyle Libre. 
It shows the level of evidence as the rank of A.32 
The fifth would be the significant exchange communication 
between patients and registered dietitian nutritionists (RDNs) by 
using FreeStyle Libre.21 The details are as follows: 
i) The patient can understand the glucose variability immediately.
ii) Blood glucose measurement is performed automatically and 
continuously, then one can grasp the eating habit as it is.
iii) One can understand how much and how to eat.
iv) The speed of blood glucose rise varies from individual to 
individual, then tailored specific guidance to each patient is 
possible.
On the other hand, there were some problems obtained from 
patient feedback.15 They are 
a) Glucose data may be sometimes interrupted by some reasons.
b) There may be some error in the value depending on the certain 
sensor, but this can be corrected.
c) Adverse effects including bleeding, pain and itching are rarely 
found in the upper arm where FreeStyle Libre is installed.
As mentioned above, FreeStyle Libre has been evaluated. In 
general, the patient’s impression for this device has been beneficial.14 
They include that 
i. The blood glucose level can be measured easily and without 
stress.
ii. The blood glucose level can be actually easily seen visually 
for 24 hours.
iii. Understanding between meal content and blood glucose has 
deepened.
iv. Patient can manage the meals without raising blood glucose.
v. As a result, FreeStyle Libre seems to be useful for the 
stabilization of blood glucose variability.
Conclusion
A diabetic female patient became pregnant with the treatment of 
CR and 48 units of insulin per day. Consecutively, due to application 
of LCD and Freestyle Libre, insulin treatment could be discontinued 
in 10 days. Consequently, the usefulness of LCD and FreeStyle Libre 
would be reported. Further development of this research will be 
expected in the future.
Acknowledgments 
None.
Funding
None.
Clinical effect for diabetic pregnant female by Low Carbohydrate Diet (LCD) and Continuous Glucose 
Monitoring (CGM)
329
Copyright:
©2019 Muneta et al.
Citation: Muneta T, Kawaguchi E, Hayashi M et al. Clinical effect for diabetic pregnant female by Low Carbohydrate Diet (LCD) and Continuous Glucose 
Monitoring (CGM). Obstet Gynecol Int J. 2019;10(4):326‒329. DOI: 10.15406/ogij.2019.10.00461
Conflicts of interest
Authors disclose no conflict of interests in publication of this study.
References
1. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes atlas: global estimates 
of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin 
Pract. 2018;138:271–281. 
2. American Diabetes Association. Pharmacologic approaches to glycemic 
treatment: standards of medical care in diabetes-2018. Diabetes Care. 
2018;41(Suppl 1):S73–S85. 
3. Schwingshackl L, Chaimani A, Hoffmann G, et al. Impact of different 
dietary approaches on glycemic control and cardiovascular risk factors 
in patients with type 2 diabetes: a protocol for a systematic review and 
network meta-analysis. Syst Rev. 2017;6(1):57. 
4. Bernstein RK. Dr. Bernstein’s Diabetes Solution. Little, New York: Brown 
and company; 1997.
5. Shai I, Schwarzfuchs D, Henkin Y, et al. Dietary intervention randomized 
controlled trial (DIRECT) group. weight loss with a low-carbohydrate, 
mediterranean, or low-fat diet. N Engl J Med. 2008;15(6):351–352.
6. Schwarzfuchs D, Golan R, Shai I. Four-year follow-up after two-year 
dietary interventions. N Engl J Med. 2012;367(14):1373–1374.
7. Feinman RD, Pogozelski WK, Astrup A, et al. Dietary carbohydrate 
restriction as the first approach in diabetes management: Critical review 
and evidence base. Nutrition. 2015;31(1):1–13. 
8. Tay J, Thompson CH, Luscombe-Marsh ND, et al. Effects of an energy-
restricted low carbohydrate, high unsaturated fat/low saturated fat diet 
versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year 
randomized clinical trial. Diabetes Obes Metab. 2018;20(4):858–871. 
9. Ebe K, Ebe Y, Yokota S, et al. Low carbohydrate diet (LCD) treated for 
three cases as diabetic diet therapy. Kyoto Medical Association Journal. 
2004;51:125–129.
10. Bando H, Ebe K, Muneta T, et al. Effect of low carbohydrate diet on 
type 2 diabetic patients and usefulness of M-value. Diabetes Res Open J. 
2017;3(1):9–16.
11. Muneta T, Kawaguchi E, Nagai Y, et al. Ketone body elevation in placenta, 
umbilical cord, newborn and mother in normal delivery. Glycative Stress 
Research. 2016;3(3):133–140.
12. Yamada S, Kabeya Y, Noto H. Dietary approaches for Japanese patients 
with diabetes: a systematic review. Nutrients. 2018;10(8):1080.
13. Sato J, Kanazawa A, Makita S, et al. A randomized controlled trial of 130 
g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control. 
Clin Nutr. 2017;36(4):992–1000. 
14. Ebe K, Bando H, Muneta T, et al. Remarkable improvement of glucose 
variability by Sodium–glucose cotransporter 2 (SGLT2) inhibitors using 
continuous glucose monitoring (CGM). Diabetes Case Rep. 2019;4:1. 
15. Bando H, Kato Y, Kanazawa S, et al. Daily improvement of blood glucose 
profile by continuous glucose monitoring (CGM). J Diabetes Metab Disord 
Control. 2019;6(2):24‒26. 
16. Japan Diabetes Association. Diabetes clinical practice guidelines Based on 
scientific evidence. 2013. 
17. Bando H, Ebe K, Muneta T, et al. Clinical effect of low carbohydrate diet 
(LCD): case report. Diabetes Case Rep. 2017;2:124. 
18. Abbott Diabetes Care. 
19. Edge J, Acerini C, Campbell F, et al. An alternative sensor-based method 
for glucose monitoring in children and young people with diabetes. Arch 
Dis Child. 2017;102(6):543–549. 
20. Nakamura T, Bando H, Kawashima T, et al. Weight reduction by effective 
protocol of diet and exercise. J Diab Obes Metab. 2019;2(1):106.
21. Muneta T, Kawaguchi E, Hayashi M, et al. Rapid efficacy of low 
carbohydrate diet for diabetic patient by use of freestyle libre. Diabetes 
Case Rep. 2019;4:138. 
22. Bando H, Ebe K, Muneta T, et al. Clinical effect of low carbohydrate diet 
(LCD): case report. Diabetes Case Rep. 2017;2:124. 
23. Ebe K, Bando H, Yamamoto K, et al. Daily carbohydrate intake correlates 
with HbA1c in low carbohydrate diet (LCD). J Diabetol. 2017;1(1):4–9.
24. Watanabe S, Hirakawa A, Utada I, et al. Ketone body production and 
excretion during wellness fasting. Diabetes Res Open J. 2017;3(1):1–8. 
25. Bando H. Ketogenic diet will be further clinically applied with positive 
effects. Endocrinol Metab. 2018;2(2):e102.
26. Updike SJ, Hicks GP. The enzyme electrode. Nature. 1967;214:986–988.
27. Skyler JS. Continuous glucose monitoring: an overview of its 
development. Diabetes Technol Ther. 2009;11(Suppl 1):S5–S10.
28. Obermaier K, Schmelzeien-Redeker G, Schoemaker M, et al. Performance 
evaluations of continuous glucose monitoring systems: precision absolute 
relative deviation is part of the assessment. J Diabetes Sci Technol. 
2013;7(4):824–832.
29. Liebl A, Henrichs HR, Heinemann L, et al. Continuous glucose monitoring 
working group of the working group diabetes technology of the German 
diabetes association: continuous glucose monitoring: evidence and 
consensus statement for clinical use. J Diabetes Sci Technol. 2013;7(2):500–
519.
30. Ólafsdóttir AF, Attvall S, Sandgren U, et al. A clinical trial of the accuracy 
and treatment experience of the flash glucose monitor freestyle libre in 
adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):164–172. 
31. Fokkert MJ, van Dijk PR, Edens MA, et al. Performance of the freestyle 
libre flash glucose monitoring system in patients with type 1 and 2 diabetes 
mellitus. BMJ Open Diabetes Res Care. 2017;17;5(1):e000320.
32. American Diabetes Association. 7. Diabetes technology: standards of 
medical care in diabetesd 2019. Diabetes Care. 2019;42(Suppl. 1):S71–
S80.
